

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 8.88563722 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 8.74824157 |
| 3 | hemidesmosome assembly (GO:0031581) | 7.83345988 |
| 4 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 7.76050274 |
| 5 | angiotensin maturation (GO:0002003) | 7.65421591 |
| 6 | virion attachment to host cell (GO:0019062) | 7.14100246 |
| 7 | adhesion of symbiont to host cell (GO:0044650) | 7.14100246 |
| 8 | regulation of bile acid biosynthetic process (GO:0070857) | 6.99575918 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.73443368 |
| 10 | adhesion of symbiont to host (GO:0044406) | 5.64870795 |
| 11 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.49924796 |
| 12 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.40554368 |
| 13 | regulation of guanylate cyclase activity (GO:0031282) | 5.21826206 |
| 14 | actin filament depolymerization (GO:0030042) | 5.12149656 |
| 15 | positive regulation of respiratory burst (GO:0060267) | 5.04919820 |
| 16 | desmosome organization (GO:0002934) | 4.84707444 |
| 17 | intestinal epithelial cell development (GO:0060576) | 4.72854825 |
| 18 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.70699410 |
| 19 | digestive system process (GO:0022600) | 4.49494866 |
| 20 | glucocorticoid biosynthetic process (GO:0006704) | 4.39357402 |
| 21 | NADH metabolic process (GO:0006734) | 4.38228471 |
| 22 | glomerular filtration (GO:0003094) | 4.35219175 |
| 23 | epithelial structure maintenance (GO:0010669) | 4.34644769 |
| 24 | vitamin A metabolic process (GO:0006776) | 4.30217946 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.29814996 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.29814996 |
| 27 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.19553830 |
| 28 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.19553830 |
| 29 | endocrine process (GO:0050886) | 4.19553830 |
| 30 | bile acid and bile salt transport (GO:0015721) | 4.15002685 |
| 31 | renal filtration (GO:0097205) | 3.97663759 |
| 32 | regulation of vitamin metabolic process (GO:0030656) | 3.94444742 |
| 33 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.93595811 |
| 34 | antibacterial humoral response (GO:0019731) | 3.82122426 |
| 35 | O-glycan processing (GO:0016266) | 3.81847443 |
| 36 | antimicrobial humoral response (GO:0019730) | 3.76503904 |
| 37 | positive regulation of pseudopodium assembly (GO:0031274) | 3.73946069 |
| 38 | hepatocyte apoptotic process (GO:0097284) | 3.73081737 |
| 39 | cellular glucuronidation (GO:0052695) | 3.72587812 |
| 40 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.71262807 |
| 41 | response to hepatocyte growth factor (GO:0035728) | 3.71262807 |
| 42 | regulation of systemic arterial blood pressure (GO:0003073) | 3.70454638 |
| 43 | renal system process involved in regulation of blood volume (GO:0001977) | 3.70328096 |
| 44 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.69688221 |
| 45 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.68115573 |
| 46 | epoxygenase P450 pathway (GO:0019373) | 3.67538696 |
| 47 | glycosphingolipid catabolic process (GO:0046479) | 3.65623331 |
| 48 | glucuronate metabolic process (GO:0019585) | 3.63148043 |
| 49 | uronic acid metabolic process (GO:0006063) | 3.63148043 |
| 50 | sulfate transmembrane transport (GO:1902358) | 3.60639765 |
| 51 | regulation of respiratory burst (GO:0060263) | 3.54536535 |
| 52 | oligosaccharide biosynthetic process (GO:0009312) | 3.53244890 |
| 53 | glycolipid catabolic process (GO:0019377) | 3.51029348 |
| 54 | neurotransmitter catabolic process (GO:0042135) | 3.49392433 |
| 55 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.47042189 |
| 56 | urea cycle (GO:0000050) | 3.46116687 |
| 57 | complement activation, classical pathway (GO:0006958) | 3.38222361 |
| 58 | drug catabolic process (GO:0042737) | 3.34375619 |
| 59 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.31951475 |
| 60 | regulation of pseudopodium assembly (GO:0031272) | 3.31371102 |
| 61 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.31155415 |
| 62 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.31155415 |
| 63 | striated muscle atrophy (GO:0014891) | 3.29105706 |
| 64 | hormone catabolic process (GO:0042447) | 3.27018773 |
| 65 | filopodium assembly (GO:0046847) | 3.26179555 |
| 66 | regulation of cGMP biosynthetic process (GO:0030826) | 3.25918703 |
| 67 | modified amino acid transport (GO:0072337) | 3.20387389 |
| 68 | urea metabolic process (GO:0019627) | 3.20198528 |
| 69 | intermediate filament organization (GO:0045109) | 3.19036299 |
| 70 | regulation of cholesterol homeostasis (GO:2000188) | 3.16925967 |
| 71 | cGMP-mediated signaling (GO:0019934) | 3.16722170 |
| 72 | lipoprotein transport (GO:0042953) | 3.15362788 |
| 73 | ethanol oxidation (GO:0006069) | 3.12700645 |
| 74 | cell communication involved in cardiac conduction (GO:0086065) | 3.12251693 |
| 75 | flavonoid metabolic process (GO:0009812) | 3.08960821 |
| 76 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.08365274 |
| 77 | lipoprotein metabolic process (GO:0042157) | 3.07972359 |
| 78 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.05359249 |
| 79 | fructose metabolic process (GO:0006000) | 3.04986180 |
| 80 | regulation of cellular extravasation (GO:0002691) | 3.04668104 |
| 81 | bicarbonate transport (GO:0015701) | 3.02756093 |
| 82 | thrombin receptor signaling pathway (GO:0070493) | 3.02742181 |
| 83 | positive regulation of p38MAPK cascade (GO:1900745) | 3.02726808 |
| 84 | negative regulation of myotube differentiation (GO:0010832) | 3.02284427 |
| 85 | cellular response to vitamin D (GO:0071305) | 3.02017618 |
| 86 | thyroid hormone metabolic process (GO:0042403) | 3.01440785 |
| 87 | NIK/NF-kappaB signaling (GO:0038061) | 2.98892496 |
| 88 | skeletal muscle adaptation (GO:0043501) | 2.98613129 |
| 89 | peptide catabolic process (GO:0043171) | 2.97999728 |
| 90 | digestion (GO:0007586) | 2.96057434 |
| 91 | sulfur compound transport (GO:0072348) | 2.94416080 |
| 92 | nitrogen cycle metabolic process (GO:0071941) | 2.94338231 |
| 93 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.93190472 |
| 94 | asymmetric protein localization (GO:0008105) | 2.92651825 |
| 95 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.92274011 |
| 96 | cellular response to vitamin (GO:0071295) | 2.90432324 |
| 97 | cholesterol homeostasis (GO:0042632) | 2.89653612 |
| 98 | sterol homeostasis (GO:0055092) | 2.88427271 |
| 99 | protein-lipid complex assembly (GO:0065005) | 2.88295920 |
| 100 | ceramide catabolic process (GO:0046514) | 2.87381724 |
| 101 | peptide hormone processing (GO:0016486) | 2.87365974 |
| 102 | plasma lipoprotein particle assembly (GO:0034377) | 2.85894340 |
| 103 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.84151465 |
| 104 | vitamin transmembrane transport (GO:0035461) | 2.83986037 |
| 105 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.82853790 |
| 106 | eosinophil chemotaxis (GO:0048245) | 2.82587064 |
| 107 | thyroid hormone generation (GO:0006590) | 2.81610117 |
| 108 | lung secretory cell differentiation (GO:0061140) | 2.81468111 |
| 109 | glycosylceramide metabolic process (GO:0006677) | 2.79290337 |
| 110 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.78324424 |
| 111 | sulfate transport (GO:0008272) | 2.78203454 |
| 112 | actin filament capping (GO:0051693) | 2.78069748 |
| 113 | muscle atrophy (GO:0014889) | 2.75757593 |
| 114 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.75192871 |
| 115 | negative regulation of cholesterol transport (GO:0032375) | 2.73725123 |
| 116 | negative regulation of sterol transport (GO:0032372) | 2.73725123 |
| 117 | drug metabolic process (GO:0017144) | 2.73704047 |
| 118 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.73268345 |
| 119 | tight junction assembly (GO:0070830) | 2.72449347 |
| 120 | auditory receptor cell differentiation (GO:0042491) | 2.72107860 |
| 121 | cardiac conduction (GO:0061337) | 2.71416235 |
| 122 | complement activation (GO:0006956) | 2.70655810 |
| 123 | phospholipid efflux (GO:0033700) | 2.68605478 |
| 124 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.67325506 |
| 125 | sphingolipid catabolic process (GO:0030149) | 2.67126256 |
| 126 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.66048094 |
| 127 | renal absorption (GO:0070293) | 2.65205666 |
| 128 | regulation of actin nucleation (GO:0051125) | 2.64333877 |
| 129 | transcytosis (GO:0045056) | 2.64216827 |
| 130 | cell-substrate junction assembly (GO:0007044) | 2.64055685 |
| 131 | cholesterol efflux (GO:0033344) | 2.63500680 |
| 132 | sodium ion homeostasis (GO:0055078) | 2.62929579 |
| 133 | glucocorticoid metabolic process (GO:0008211) | 2.61746333 |
| 134 | protein localization to endosome (GO:0036010) | 2.61625443 |
| 135 | sulfation (GO:0051923) | 2.60609391 |
| 136 | regulation of RIG-I signaling pathway (GO:0039535) | 2.59415573 |
| 137 | cholesterol transport (GO:0030301) | 2.59401565 |
| 138 | sterol transport (GO:0015918) | 2.59401565 |
| 139 | regulation of cGMP metabolic process (GO:0030823) | 2.58576145 |
| 140 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.58498928 |
| 141 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.58203280 |
| 142 | sodium ion export (GO:0071436) | 2.55267947 |
| 143 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.53738224 |
| 144 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.53257245 |
| 145 | transepithelial transport (GO:0070633) | 2.52684310 |
| 146 | glucose 6-phosphate metabolic process (GO:0051156) | 2.52544547 |
| 147 | multicellular organismal water homeostasis (GO:0050891) | 2.52247961 |
| 148 | keratinocyte proliferation (GO:0043616) | 2.51739506 |
| 149 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.51362460 |
| 150 | epithelial cell-cell adhesion (GO:0090136) | 2.51320574 |
| 151 | membrane lipid catabolic process (GO:0046466) | 2.51163437 |
| 152 | regulation of extracellular matrix disassembly (GO:0010715) | 2.51030313 |
| 153 | regulation of viral release from host cell (GO:1902186) | 2.50603272 |
| 154 | ethanol metabolic process (GO:0006067) | 2.50344587 |
| 155 | negative regulation of steroid biosynthetic process (GO:0010894) | 2.50014211 |
| 156 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.49032267 |
| 157 | sexual reproduction (GO:0019953) | 2.48973470 |
| 158 | drug transport (GO:0015893) | 2.48919253 |
| 159 | diol metabolic process (GO:0034311) | 2.48760280 |
| 160 | eosinophil migration (GO:0072677) | 2.48381085 |
| 161 | sphingomyelin metabolic process (GO:0006684) | 2.46048892 |
| 162 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.45564703 |
| 163 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.45564703 |
| 164 | diacylglycerol metabolic process (GO:0046339) | 2.45473273 |
| 165 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.45164359 |
| 166 | positive regulation of actin filament depolymerization (GO:0030836) | 2.44393606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.79466973 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.98526157 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.85179256 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.78642560 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.71537307 |
| 6 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.54301034 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.46638959 |
| 8 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.21957751 |
| 9 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.15463306 |
| 10 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.14016094 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.09579040 |
| 12 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.00288744 |
| 13 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.95044201 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.86219226 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.85833168 |
| 16 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.84302016 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83754073 |
| 18 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.80608858 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80572850 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.79829121 |
| 21 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.78187049 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76777530 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76244437 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75089407 |
| 25 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.75079823 |
| 26 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.65886517 |
| 27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.64563378 |
| 28 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.64424426 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.62369681 |
| 30 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.62262325 |
| 31 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59870517 |
| 32 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.59804534 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56575433 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55963164 |
| 35 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.53823925 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50649114 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49759674 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.45429631 |
| 39 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.44830488 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.43927511 |
| 41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41234171 |
| 42 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40905335 |
| 43 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39740185 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38098178 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35445854 |
| 46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34230350 |
| 47 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32175958 |
| 48 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.27839675 |
| 49 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.27839675 |
| 50 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.27308610 |
| 51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.27123442 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25421508 |
| 53 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25362352 |
| 54 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.24621462 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22063155 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.21863573 |
| 57 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20600113 |
| 58 | GATA2_19941826_ChIP-Seq_K562_Human | 1.20151173 |
| 59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19944420 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18881352 |
| 61 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15300370 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14753498 |
| 63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13143355 |
| 64 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.13072929 |
| 65 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.11293264 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10349693 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08894724 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08280288 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07359160 |
| 70 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05839846 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05109745 |
| 72 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04920551 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04166872 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03610157 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02427585 |
| 76 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02042224 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01842968 |
| 78 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00793206 |
| 79 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99745145 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99259955 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98130724 |
| 82 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.97889815 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97882985 |
| 84 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97746240 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97000830 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96790062 |
| 87 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.96739346 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96051878 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94966391 |
| 90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94635776 |
| 91 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93597028 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93214418 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93115150 |
| 94 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92529512 |
| 95 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91777109 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91684797 |
| 97 | SA1_27219007_Chip-Seq_Bcells_Human | 0.91406574 |
| 98 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.90612935 |
| 99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90077682 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89534398 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89427818 |
| 102 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89157122 |
| 103 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88759302 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88489158 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86950253 |
| 106 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.86920522 |
| 107 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86522771 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85356928 |
| 109 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84624074 |
| 110 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.84578945 |
| 111 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84316989 |
| 112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84051032 |
| 113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83613509 |
| 114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83515327 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.83506876 |
| 116 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82345017 |
| 117 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82237523 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 0.81960608 |
| 119 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.81929791 |
| 120 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.81771721 |
| 121 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81708474 |
| 122 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.79288843 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79219954 |
| 124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79082781 |
| 125 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.79010999 |
| 126 | KDM2B_26808549_Chip-Seq_K562_Human | 0.78403029 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77924067 |
| 128 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77841685 |
| 129 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.77653370 |
| 130 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.77256971 |
| 131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.77172519 |
| 132 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.76881407 |
| 133 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.75182361 |
| 134 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73558030 |
| 135 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.73448256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 7.98897217 |
| 2 | MP0005360_urolithiasis | 5.75229957 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.90834169 |
| 4 | MP0001666_abnormal_nutrient_absorption | 3.85714839 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.64285145 |
| 6 | MP0001873_stomach_inflammation | 3.36700043 |
| 7 | MP0001346_abnormal_lacrimal_gland | 3.36578011 |
| 8 | MP0004043_abnormal_pH_regulation | 2.84242019 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.84075919 |
| 10 | MP0002876_abnormal_thyroid_physiology | 2.75699270 |
| 11 | MP0003866_abnormal_defecation | 2.56948168 |
| 12 | MP0005310_abnormal_salivary_gland | 2.55167730 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.39913689 |
| 14 | MP0000462_abnormal_digestive_system | 2.39716002 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.39664614 |
| 16 | MP0001348_abnormal_lacrimal_gland | 2.26634588 |
| 17 | MP0008004_abnormal_stomach_pH | 2.24123160 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.21604861 |
| 19 | MP0010155_abnormal_intestine_physiology | 2.21532440 |
| 20 | MP0010678_abnormal_skin_adnexa | 2.18766049 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.14726814 |
| 22 | MP0000538_abnormal_urinary_bladder | 2.11994741 |
| 23 | MP0000465_gastrointestinal_hemorrhage | 2.05779492 |
| 24 | MP0001849_ear_inflammation | 1.94807234 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.94383732 |
| 26 | MP0001663_abnormal_digestive_system | 1.93512243 |
| 27 | MP0005409_darkened_coat_color | 1.92149920 |
| 28 | MP0003303_peritoneal_inflammation | 1.87775106 |
| 29 | MP0003453_abnormal_keratinocyte_physiol | 1.86173072 |
| 30 | MP0005381_digestive/alimentary_phenotyp | 1.83249715 |
| 31 | MP0002796_impaired_skin_barrier | 1.82945750 |
| 32 | MP0000537_abnormal_urethra_morphology | 1.80966769 |
| 33 | MP0000516_abnormal_urinary_system | 1.80956328 |
| 34 | MP0005367_renal/urinary_system_phenotyp | 1.80956328 |
| 35 | MP0003252_abnormal_bile_duct | 1.71313484 |
| 36 | MP0000383_abnormal_hair_follicle | 1.65958819 |
| 37 | MP0003724_increased_susceptibility_to | 1.65950840 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.61436985 |
| 39 | MP0000685_abnormal_immune_system | 1.50986453 |
| 40 | MP0000477_abnormal_intestine_morphology | 1.47267774 |
| 41 | MP0000467_abnormal_esophagus_morphology | 1.40751721 |
| 42 | MP0005365_abnormal_bile_salt | 1.38955129 |
| 43 | MP0000579_abnormal_nail_morphology | 1.38362896 |
| 44 | MP0003436_decreased_susceptibility_to | 1.37461649 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.34946389 |
| 46 | MP0003878_abnormal_ear_physiology | 1.34224757 |
| 47 | MP0005377_hearing/vestibular/ear_phenot | 1.34224757 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 1.30698224 |
| 49 | MP0009785_altered_susceptibility_to | 1.28603637 |
| 50 | MP0001664_abnormal_digestion | 1.26778885 |
| 51 | MP0000613_abnormal_salivary_gland | 1.26335362 |
| 52 | MP0005025_abnormal_response_to | 1.24537539 |
| 53 | MP0000681_abnormal_thyroid_gland | 1.23165836 |
| 54 | MP0002098_abnormal_vibrissa_morphology | 1.22597698 |
| 55 | MP0004947_skin_inflammation | 1.21068713 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.19511119 |
| 57 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18341523 |
| 58 | MP0000470_abnormal_stomach_morphology | 1.18058825 |
| 59 | MP0005670_abnormal_white_adipose | 1.16447137 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.16149679 |
| 61 | MP0001216_abnormal_epidermal_layer | 1.14161783 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.06984514 |
| 63 | MP0002896_abnormal_bone_mineralization | 1.06128279 |
| 64 | MP0003879_abnormal_hair_cell | 1.05378031 |
| 65 | MP0001485_abnormal_pinna_reflex | 1.04990710 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.04135394 |
| 67 | MP0006082_CNS_inflammation | 1.03773386 |
| 68 | MP0005501_abnormal_skin_physiology | 1.02746876 |
| 69 | MP0002822_catalepsy | 1.02692055 |
| 70 | MP0002060_abnormal_skin_morphology | 1.01472410 |
| 71 | MP0005165_increased_susceptibility_to | 0.99441892 |
| 72 | MP0006054_spinal_hemorrhage | 0.99004398 |
| 73 | MP0002148_abnormal_hypersensitivity_rea | 0.98616682 |
| 74 | MP0009840_abnormal_foam_cell | 0.98361086 |
| 75 | MP0004147_increased_porphyrin_level | 0.98161073 |
| 76 | MP0005451_abnormal_body_composition | 0.97064060 |
| 77 | MP0001764_abnormal_homeostasis | 0.96902151 |
| 78 | MP0001756_abnormal_urination | 0.96522232 |
| 79 | MP0009384_cardiac_valve_regurgitation | 0.94915861 |
| 80 | MP0005332_abnormal_amino_acid | 0.94602589 |
| 81 | MP0000678_abnormal_parathyroid_gland | 0.94574726 |
| 82 | MP0003045_fibrosis | 0.92200457 |
| 83 | MP0005023_abnormal_wound_healing | 0.91554864 |
| 84 | MP0001501_abnormal_sleep_pattern | 0.90504392 |
| 85 | MP0009643_abnormal_urine_homeostasis | 0.90394062 |
| 86 | MP0003868_abnormal_feces_composition | 0.90362519 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.90218051 |
| 88 | MP0005448_abnormal_energy_balance | 0.87949084 |
| 89 | MP0005671_abnormal_response_to | 0.87622636 |
| 90 | MP0001835_abnormal_antigen_presentation | 0.87323939 |
| 91 | MP0001800_abnormal_humoral_immune | 0.86575600 |
| 92 | MP0004019_abnormal_vitamin_homeostasis | 0.86182318 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.85130258 |
| 94 | MP0000490_abnormal_crypts_of | 0.84757285 |
| 95 | MP0002971_abnormal_brown_adipose | 0.84279701 |
| 96 | MP0008469_abnormal_protein_level | 0.83054266 |
| 97 | MP0001881_abnormal_mammary_gland | 0.82953250 |
| 98 | MP0002419_abnormal_innate_immunity | 0.82875573 |
| 99 | MP0009333_abnormal_splenocyte_physiolog | 0.81900602 |
| 100 | MP0000427_abnormal_hair_cycle | 0.79204013 |
| 101 | MP0000377_abnormal_hair_follicle | 0.78860854 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77520478 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.77257567 |
| 104 | MP0000249_abnormal_blood_vessel | 0.76918980 |
| 105 | MP0002452_abnormal_antigen_presenting | 0.74778723 |
| 106 | MP0003091_abnormal_cell_migration | 0.73413574 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.71912021 |
| 108 | MP0004858_abnormal_nervous_system | 0.71857798 |
| 109 | MP0005166_decreased_susceptibility_to | 0.70985417 |
| 110 | MP0005666_abnormal_adipose_tissue | 0.70515547 |
| 111 | MP0010771_integument_phenotype | 0.70050011 |
| 112 | MP0005000_abnormal_immune_tolerance | 0.68122928 |
| 113 | MP0001790_abnormal_immune_system | 0.66170061 |
| 114 | MP0005387_immune_system_phenotype | 0.66170061 |
| 115 | MP0000762_abnormal_tongue_morphology | 0.64580823 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.64288793 |
| 117 | MP0001845_abnormal_inflammatory_respons | 0.64281731 |
| 118 | MP0000627_abnormal_mammary_gland | 0.64102876 |
| 119 | MP0000609_abnormal_liver_physiology | 0.63391154 |
| 120 | MP0000566_synostosis | 0.61939237 |
| 121 | MP0009053_abnormal_anal_canal | 0.60128513 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.60023793 |
| 123 | MP0003075_altered_response_to | 0.59704339 |
| 124 | MP0001851_eye_inflammation | 0.57745513 |
| 125 | MP0008872_abnormal_physiological_respon | 0.57091049 |
| 126 | MP0002166_altered_tumor_susceptibility | 0.56346914 |
| 127 | MP0002009_preneoplasia | 0.53584256 |
| 128 | MP0004782_abnormal_surfactant_physiolog | 0.52012537 |
| 129 | MP0002877_abnormal_melanocyte_morpholog | 0.51895611 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.51380326 |
| 131 | MP0002138_abnormal_hepatobiliary_system | 0.51083736 |
| 132 | MP0001191_abnormal_skin_condition | 0.50794592 |
| 133 | MP0005275_abnormal_skin_tensile | 0.50468336 |
| 134 | MP0005084_abnormal_gallbladder_morpholo | 0.50304361 |
| 135 | MP0002089_abnormal_postnatal_growth/wei | 0.50095493 |
| 136 | MP0003329_amyloid_beta_deposits | 0.49536042 |
| 137 | MP0000604_amyloidosis | 0.48969668 |
| 138 | MP0004510_myositis | 0.48761610 |
| 139 | MP0003191_abnormal_cellular_cholesterol | 0.48639193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 7.82485358 |
| 2 | Ileus (HP:0002595) | 6.33194526 |
| 3 | Milia (HP:0001056) | 6.29698749 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.90452419 |
| 5 | Decreased circulating renin level (HP:0003351) | 5.69749458 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.55871207 |
| 7 | Abnormality of proline metabolism (HP:0010907) | 5.11702062 |
| 8 | Hydroxyprolinuria (HP:0003080) | 5.11702062 |
| 9 | Onycholysis (HP:0001806) | 5.01240273 |
| 10 | Abnormality of renin-angiotensin system (HP:0000847) | 4.79268920 |
| 11 | Plantar hyperkeratosis (HP:0007556) | 4.74391875 |
| 12 | Atrophic scars (HP:0001075) | 4.70797382 |
| 13 | Metabolic alkalosis (HP:0200114) | 4.67399816 |
| 14 | Glomerulonephritis (HP:0000099) | 4.53195583 |
| 15 | Fragile nails (HP:0001808) | 4.43547025 |
| 16 | Abnormality of the gastric mucosa (HP:0004295) | 4.32806716 |
| 17 | Complement deficiency (HP:0004431) | 4.00230080 |
| 18 | Pili torti (HP:0003777) | 3.99468616 |
| 19 | Malnutrition (HP:0004395) | 3.94917769 |
| 20 | Congenital sensorineural hearing impairment (HP:0008527) | 3.92628659 |
| 21 | Acanthocytosis (HP:0001927) | 3.80012446 |
| 22 | Hypoplasia of dental enamel (HP:0006297) | 3.72167647 |
| 23 | Alkalosis (HP:0001948) | 3.65693428 |
| 24 | Chronic diarrhea (HP:0002028) | 3.60653411 |
| 25 | Abnormality of complement system (HP:0005339) | 3.58354868 |
| 26 | Woolly hair (HP:0002224) | 3.57455480 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.56020970 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.56020970 |
| 29 | Thin bony cortex (HP:0002753) | 3.53774349 |
| 30 | Hyperaldosteronism (HP:0000859) | 3.51603815 |
| 31 | Hemorrhage of the eye (HP:0011885) | 3.43972922 |
| 32 | Increased IgE level (HP:0003212) | 3.30780201 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.26899016 |
| 34 | Abdominal distention (HP:0003270) | 3.26461732 |
| 35 | Fatigable weakness (HP:0003473) | 3.25031413 |
| 36 | Abnormality of the neuromuscular junction (HP:0003398) | 3.25031413 |
| 37 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.23390515 |
| 38 | Villous atrophy (HP:0011473) | 3.23390515 |
| 39 | Hypobetalipoproteinemia (HP:0003563) | 3.23283359 |
| 40 | Fragile skin (HP:0001030) | 3.16467162 |
| 41 | Nephritis (HP:0000123) | 3.10649706 |
| 42 | Palmoplantar hyperkeratosis (HP:0000972) | 3.08697400 |
| 43 | Fat malabsorption (HP:0002630) | 2.99861868 |
| 44 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.99731911 |
| 45 | Pustule (HP:0200039) | 2.99600847 |
| 46 | Palmar hyperkeratosis (HP:0010765) | 2.84993771 |
| 47 | Flat acetabular roof (HP:0003180) | 2.82805665 |
| 48 | Ureteral stenosis (HP:0000071) | 2.82450796 |
| 49 | Nail dystrophy (HP:0008404) | 2.80585146 |
| 50 | Lip pit (HP:0100267) | 2.76704908 |
| 51 | Keratoconjunctivitis (HP:0001096) | 2.76144829 |
| 52 | Rectal prolapse (HP:0002035) | 2.72547940 |
| 53 | Hyperparathyroidism (HP:0000843) | 2.65300822 |
| 54 | Ureteral obstruction (HP:0006000) | 2.62684445 |
| 55 | Esophageal atresia (HP:0002032) | 2.62531496 |
| 56 | Alopecia of scalp (HP:0002293) | 2.60349087 |
| 57 | Neonatal short-limb short stature (HP:0008921) | 2.56628067 |
| 58 | Abnormality of vitamin B metabolism (HP:0004340) | 2.56386313 |
| 59 | Palpitations (HP:0001962) | 2.55513887 |
| 60 | Abnormal hair laboratory examination (HP:0003328) | 2.53797857 |
| 61 | Amelogenesis imperfecta (HP:0000705) | 2.53336075 |
| 62 | Hypercortisolism (HP:0001578) | 2.52515047 |
| 63 | Dehydration (HP:0001944) | 2.52031552 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.51275770 |
| 65 | Delayed epiphyseal ossification (HP:0002663) | 2.49419165 |
| 66 | Abnormality of potassium homeostasis (HP:0011042) | 2.48670131 |
| 67 | Hypokalemia (HP:0002900) | 2.47998094 |
| 68 | Abnormal blistering of the skin (HP:0008066) | 2.47741538 |
| 69 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.46300817 |
| 70 | Thick nail (HP:0001805) | 2.46231589 |
| 71 | Flattened epiphyses (HP:0003071) | 2.44662270 |
| 72 | Hyperkalemia (HP:0002153) | 2.44333554 |
| 73 | Hyponatremia (HP:0002902) | 2.43380069 |
| 74 | Ventricular tachycardia (HP:0004756) | 2.40297288 |
| 75 | Aplasia cutis congenita (HP:0001057) | 2.35704036 |
| 76 | Recurrent fungal infections (HP:0002841) | 2.33922763 |
| 77 | Hyperactive renin-angiotensin system (HP:0000841) | 2.32957255 |
| 78 | Gastrointestinal dysmotility (HP:0002579) | 2.31388692 |
| 79 | Axonal loss (HP:0003447) | 2.30566892 |
| 80 | Curly hair (HP:0002212) | 2.30485340 |
| 81 | Poikilocytosis (HP:0004447) | 2.28001285 |
| 82 | Gingivitis (HP:0000230) | 2.27719238 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 2.24224096 |
| 84 | Abnormality of vitamin metabolism (HP:0100508) | 2.23757855 |
| 85 | Enlarged epiphyses (HP:0010580) | 2.23621740 |
| 86 | Pterygium (HP:0001059) | 2.23199332 |
| 87 | Wide cranial sutures (HP:0010537) | 2.23058608 |
| 88 | Chronic otitis media (HP:0000389) | 2.22409346 |
| 89 | Micronodular cirrhosis (HP:0001413) | 2.20724690 |
| 90 | Intrahepatic cholestasis (HP:0001406) | 2.18293860 |
| 91 | Myopathic facies (HP:0002058) | 2.17544474 |
| 92 | Colitis (HP:0002583) | 2.16284318 |
| 93 | Abnormality of the nasal mucosa (HP:0000433) | 2.13694418 |
| 94 | Hypotension (HP:0002615) | 2.12822669 |
| 95 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.11168162 |
| 96 | Eczematoid dermatitis (HP:0000976) | 2.11004276 |
| 97 | Confusion (HP:0001289) | 2.09376224 |
| 98 | Xanthomatosis (HP:0000991) | 2.08302869 |
| 99 | Pigmentary retinal degeneration (HP:0001146) | 2.07993163 |
| 100 | Adrenal overactivity (HP:0002717) | 2.07508610 |
| 101 | Visceral angiomatosis (HP:0100761) | 2.06869767 |
| 102 | Focal segmental glomerulosclerosis (HP:0000097) | 2.03600163 |
| 103 | Syncope (HP:0001279) | 2.03496276 |
| 104 | Bone pain (HP:0002653) | 2.03344882 |
| 105 | Hypophosphatemia (HP:0002148) | 2.02426584 |
| 106 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.01958103 |
| 107 | Cholelithiasis (HP:0001081) | 1.98849182 |
| 108 | Progressive sensorineural hearing impairment (HP:0000408) | 1.98809496 |
| 109 | Abnormality of the costochondral junction (HP:0000919) | 1.96856703 |
| 110 | Abnormal tarsal ossification (HP:0008369) | 1.96583465 |
| 111 | Premature loss of primary teeth (HP:0006323) | 1.96415003 |
| 112 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.94181358 |
| 113 | Abnormal biliary tract morphology (HP:0012440) | 1.92724101 |
| 114 | Ridged nail (HP:0001807) | 1.90228599 |
| 115 | Cerebral aneurysm (HP:0004944) | 1.89789222 |
| 116 | Nasal polyposis (HP:0100582) | 1.89112695 |
| 117 | Hoarse voice (HP:0001609) | 1.88638691 |
| 118 | Microretrognathia (HP:0000308) | 1.88072797 |
| 119 | Protuberant abdomen (HP:0001538) | 1.88055199 |
| 120 | Tongue fasciculations (HP:0001308) | 1.87507580 |
| 121 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.87399047 |
| 122 | Ventricular fibrillation (HP:0001663) | 1.87254886 |
| 123 | Hepatitis (HP:0012115) | 1.84477857 |
| 124 | Inflammation of the large intestine (HP:0002037) | 1.83893563 |
| 125 | Hypolipoproteinemia (HP:0010981) | 1.83481577 |
| 126 | Asplenia (HP:0001746) | 1.83277227 |
| 127 | Abnormality of sodium homeostasis (HP:0010931) | 1.82700487 |
| 128 | Cupped ribs (HP:0000887) | 1.81250511 |
| 129 | Type I diabetes mellitus (HP:0100651) | 1.80908753 |
| 130 | Epidermoid cyst (HP:0200040) | 1.80523968 |
| 131 | Hyperphosphatemia (HP:0002905) | 1.80380793 |
| 132 | Abnormal gallbladder morphology (HP:0012437) | 1.80344397 |
| 133 | Increased mean platelet volume (HP:0011877) | 1.78375538 |
| 134 | Hemangiomatosis (HP:0007461) | 1.78301788 |
| 135 | Abnormality of carpal bone ossification (HP:0006257) | 1.77176942 |
| 136 | Abnormality of chloride homeostasis (HP:0011422) | 1.77119684 |
| 137 | Widely patent fontanelles and sutures (HP:0004492) | 1.75740300 |
| 138 | Esophageal varix (HP:0002040) | 1.75576267 |
| 139 | Nephrolithiasis (HP:0000787) | 1.74323342 |
| 140 | Vacuolated lymphocytes (HP:0001922) | 1.73332615 |
| 141 | Ventricular arrhythmia (HP:0004308) | 1.72951418 |
| 142 | Progressive hearing impairment (HP:0001730) | 1.71926420 |
| 143 | Biliary tract neoplasm (HP:0100574) | 1.71231294 |
| 144 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.70680473 |
| 145 | Flat capital femoral epiphysis (HP:0003370) | 1.68738118 |
| 146 | Abnormal glucose tolerance (HP:0001952) | 1.68540037 |
| 147 | Goiter (HP:0000853) | 1.68530059 |
| 148 | Nausea (HP:0002018) | 1.68000847 |
| 149 | Spinal cord compression (HP:0002176) | 1.66550124 |
| 150 | Amyloidosis (HP:0011034) | 1.65847912 |
| 151 | Petechiae (HP:0000967) | 1.64130245 |
| 152 | Renal tubular acidosis (HP:0001947) | 1.64029051 |
| 153 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.61441802 |
| 154 | Abnormality of macrophages (HP:0004311) | 1.61440919 |
| 155 | Dysostosis multiplex (HP:0000943) | 1.59764952 |
| 156 | Metaphyseal irregularity (HP:0003025) | 1.59539327 |
| 157 | Spontaneous hematomas (HP:0007420) | 1.58944781 |
| 158 | Glomerulosclerosis (HP:0000096) | 1.58534261 |
| 159 | Hyperammonemia (HP:0001987) | 1.57448211 |
| 160 | Abnormality of glycolipid metabolism (HP:0010969) | 1.56987439 |
| 161 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.56987439 |
| 162 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.56987439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.18173367 |
| 2 | ACVR1B | 5.00536187 |
| 3 | MST4 | 4.80818361 |
| 4 | NME1 | 4.29376250 |
| 5 | LMTK2 | 3.94235061 |
| 6 | MST1R | 2.98660232 |
| 7 | EPHB1 | 2.77145835 |
| 8 | PTK6 | 2.53977682 |
| 9 | EPHA2 | 2.40469794 |
| 10 | EPHA3 | 2.30225838 |
| 11 | MAP3K14 | 2.27434674 |
| 12 | PRKG2 | 2.23648232 |
| 13 | AKT3 | 2.20930470 |
| 14 | RIPK1 | 2.20917742 |
| 15 | MAPK15 | 2.17661473 |
| 16 | MAP2K2 | 2.07095936 |
| 17 | STK39 | 1.96980783 |
| 18 | FGFR4 | 1.96382567 |
| 19 | MAP3K10 | 1.85493917 |
| 20 | ERN1 | 1.82502900 |
| 21 | FER | 1.82277891 |
| 22 | MAP3K2 | 1.78734580 |
| 23 | GRK6 | 1.75422049 |
| 24 | EPHB2 | 1.68316003 |
| 25 | PTK2 | 1.62781789 |
| 26 | TRIB3 | 1.56483931 |
| 27 | LATS1 | 1.54048971 |
| 28 | OXSR1 | 1.48126232 |
| 29 | TESK1 | 1.46979879 |
| 30 | PDK2 | 1.38339876 |
| 31 | TGFBR2 | 1.37188444 |
| 32 | BLK | 1.36386755 |
| 33 | MAP3K7 | 1.36228720 |
| 34 | TYK2 | 1.35862383 |
| 35 | DDR2 | 1.33555729 |
| 36 | PRPF4B | 1.32352896 |
| 37 | WNK4 | 1.27318910 |
| 38 | PIK3CA | 1.25083925 |
| 39 | STK10 | 1.22526200 |
| 40 | MAP4K1 | 1.21090043 |
| 41 | MATK | 1.15828798 |
| 42 | FGFR3 | 1.13214238 |
| 43 | ERBB2 | 1.10876898 |
| 44 | CSF1R | 1.07221890 |
| 45 | STK24 | 1.04919078 |
| 46 | NUAK1 | 1.04200906 |
| 47 | PDPK1 | 1.03002909 |
| 48 | SMG1 | 1.01353247 |
| 49 | TESK2 | 0.96656632 |
| 50 | TBK1 | 0.96012271 |
| 51 | CDC42BPA | 0.95144285 |
| 52 | MET | 0.95047962 |
| 53 | IKBKE | 0.89491212 |
| 54 | NLK | 0.88169759 |
| 55 | SCYL2 | 0.86723492 |
| 56 | TAOK1 | 0.85830960 |
| 57 | RPS6KB2 | 0.84793234 |
| 58 | CHUK | 0.84061622 |
| 59 | PDK1 | 0.83970303 |
| 60 | KSR2 | 0.83567913 |
| 61 | LRRK2 | 0.82760233 |
| 62 | MYLK | 0.81303617 |
| 63 | MAP2K1 | 0.80788675 |
| 64 | ITK | 0.79533192 |
| 65 | ZAP70 | 0.76153378 |
| 66 | JAK1 | 0.74652293 |
| 67 | PAK4 | 0.71336520 |
| 68 | PRKCI | 0.70448689 |
| 69 | MAPKAPK3 | 0.70105920 |
| 70 | MAP3K13 | 0.70082089 |
| 71 | JAK3 | 0.69178613 |
| 72 | PRKAA2 | 0.67333759 |
| 73 | DMPK | 0.66804749 |
| 74 | RIPK4 | 0.66240503 |
| 75 | IRAK3 | 0.64545957 |
| 76 | MAP3K1 | 0.64396867 |
| 77 | MAP3K11 | 0.63870438 |
| 78 | PAK2 | 0.61687064 |
| 79 | JAK2 | 0.61445385 |
| 80 | MAP3K8 | 0.60244774 |
| 81 | BMPR1B | 0.59904294 |
| 82 | IRAK1 | 0.58777762 |
| 83 | SIK1 | 0.58082537 |
| 84 | MAP3K3 | 0.57197237 |
| 85 | DYRK1B | 0.56650336 |
| 86 | BMX | 0.53717423 |
| 87 | TSSK6 | 0.52906630 |
| 88 | RPS6KA2 | 0.52066102 |
| 89 | ICK | 0.51387965 |
| 90 | DYRK3 | 0.50429178 |
| 91 | MAPK11 | 0.48495659 |
| 92 | MAPK7 | 0.46585236 |
| 93 | MAPKAPK2 | 0.46570751 |
| 94 | PAK3 | 0.45402037 |
| 95 | ABL2 | 0.45126160 |
| 96 | KIT | 0.44386806 |
| 97 | SRC | 0.44169189 |
| 98 | RET | 0.42531260 |
| 99 | MAP2K6 | 0.41489452 |
| 100 | PRKACG | 0.41393201 |
| 101 | NEK6 | 0.40695319 |
| 102 | PDGFRA | 0.38716538 |
| 103 | LYN | 0.38504358 |
| 104 | CDK9 | 0.38475732 |
| 105 | TGFBR1 | 0.37680603 |
| 106 | PDGFRB | 0.36834954 |
| 107 | MELK | 0.36439371 |
| 108 | CSK | 0.34702277 |
| 109 | LIMK1 | 0.34532393 |
| 110 | BTK | 0.34302211 |
| 111 | FGR | 0.34269743 |
| 112 | RPS6KC1 | 0.34086968 |
| 113 | RPS6KL1 | 0.34086968 |
| 114 | SYK | 0.33755935 |
| 115 | TNIK | 0.32967785 |
| 116 | DAPK2 | 0.32842064 |
| 117 | EEF2K | 0.32759559 |
| 118 | BCR | 0.31827353 |
| 119 | PRKD2 | 0.31729977 |
| 120 | LCK | 0.31497920 |
| 121 | PRKCA | 0.31423922 |
| 122 | CAMK2G | 0.30609302 |
| 123 | GRK7 | 0.30292994 |
| 124 | CDK6 | 0.30033604 |
| 125 | STK3 | 0.30028756 |
| 126 | FGFR2 | 0.28543116 |
| 127 | YES1 | 0.28209985 |
| 128 | GSK3A | 0.27867080 |
| 129 | INSRR | 0.27689680 |
| 130 | IGF1R | 0.27602425 |
| 131 | RPS6KA1 | 0.27539142 |
| 132 | ROCK1 | 0.27456854 |
| 133 | MAP3K9 | 0.27119542 |
| 134 | STK11 | 0.26538004 |
| 135 | ROCK2 | 0.25450555 |
| 136 | TTN | 0.24529260 |
| 137 | TYRO3 | 0.23266068 |
| 138 | CAMK2D | 0.22981513 |
| 139 | PRKAA1 | 0.20837911 |
| 140 | FYN | 0.20808156 |
| 141 | PKN2 | 0.19076896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.45896463 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 3.74144387 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.62231540 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.38229275 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.96102468 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.89027658 |
| 7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.78927537 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.38784888 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.34107109 |
| 10 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.32638266 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 2.27425514 |
| 12 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.21211440 |
| 13 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.11802779 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.95557818 |
| 15 | Galactose metabolism_Homo sapiens_hsa00052 | 1.94846813 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.82655349 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.76236385 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.67284416 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.61313148 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.60645933 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.58002756 |
| 22 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38810451 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.38712190 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.33831506 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.31168913 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.30429208 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.28133867 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.25725879 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24476880 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15799592 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15401874 |
| 32 | Tight junction_Homo sapiens_hsa04530 | 1.13107927 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05142355 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.04939449 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.02029786 |
| 36 | Adherens junction_Homo sapiens_hsa04520 | 0.98719858 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97143964 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.96817032 |
| 39 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.94638877 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.94540490 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 0.94434194 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93881977 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.93829532 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93739360 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92631038 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91878748 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90117207 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88864698 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.86953505 |
| 50 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.86485524 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86185040 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85333471 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82394279 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.82034645 |
| 55 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79604962 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79253072 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78422563 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78116059 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77381214 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75940720 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75458284 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.74599054 |
| 63 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72871407 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72584873 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70928371 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.70364074 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66491443 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.63653110 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.63589279 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61657573 |
| 71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61656988 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59045487 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58428441 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57888212 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.57239056 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56271128 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56028027 |
| 78 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53435393 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52822335 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52691171 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.52192919 |
| 82 | Salivary secretion_Homo sapiens_hsa04970 | 0.51484064 |
| 83 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51153367 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50321973 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49970223 |
| 86 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49479095 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48464677 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47966738 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47761367 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47237158 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.46612732 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.45820125 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.44295014 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42127534 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41083113 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40810580 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40396988 |
| 98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39696820 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38296962 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37815276 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36092863 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35383825 |
| 103 | Apoptosis_Homo sapiens_hsa04210 | 0.34891690 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34568424 |
| 105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34493470 |
| 106 | Focal adhesion_Homo sapiens_hsa04510 | 0.33918286 |
| 107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32993595 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32936528 |
| 109 | Tuberculosis_Homo sapiens_hsa05152 | 0.32559085 |
| 110 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31096630 |
| 111 | Asthma_Homo sapiens_hsa05310 | 0.30132757 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30028540 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29833376 |
| 114 | Renin secretion_Homo sapiens_hsa04924 | 0.29208364 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29136015 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25871189 |
| 117 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.25723222 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.25180928 |
| 119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.23871166 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.22988805 |
| 121 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.22484398 |
| 122 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.22475269 |
| 123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.22379481 |
| 124 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.21865786 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.21816814 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.21415839 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20970738 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20301272 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.19348985 |

